References
- Peters SP, Schulman ES, Schleimer RP, Mac Glashan DW, Newball HH, Lichtenstein LM. Dispersed human lung mast cells. Pharmacological aspects and comparison with human lung tissue fragments. Am Rev Resp Dis. 1982; 126: 1034–9.
- Hegardt B, Pauwels R, Van Der Straeten M. Inhibitory effect of KWD 2131, terbutaline and DSCG on the immediate and late allergeninduced bronchoconstriction. Allergy. 1981; 36: 115 22.
- Persson CGP, Svensjo E. Airway hyperreactivity and microvascular permeability to large molecules. Eur J Resp Dis. 1983; 64: 183–214.
- Wanner A. Clinical aspects of mucociliary treatment. Am Rev Resp Dis. 1977; 116: 73125.
- Sutton PP, Pavia D, Bateman JRM, Clarke SW. The effect of oral aminophylline on lung mucociliary clearance in man. Chest. 1981; 80: 889.
- Pauwels R, Van Der Straeten M. The antiallergic effect of theophylline. In: Jonkman JHG, Jenne JW, Simons FER. Sustained release theophylline in the treatment of chronic reversible airways obstruction. Excerpta Medica, Amsterdam 1983: 9–13.
- Nadel JA. Regulation of bronchial secretions. In: Newball HH. Immunopharmacology of the lung. Marcel Dekker, New York, 1983: 109–39.
- Petrie GR, Palmer KNV. Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma. Br Med J. 1975; 1: 430–82.
- Ullah MI, Newman GB and Saunders KB. Influence of age on response to ipratropium and salbutamol in asthma. Thorax. 1981; 36: 5239.
- Ruffln RE, Fitzgerald JD, Rebuck AS. A comparison of the bronchodilator activity of Sch 1000 and salbutamol. J A llergv Clin Immunol. 1977; 58: 136–41.
- Ward MJ, Fentem PH, Roderick-Smith WH, Davies D. Ipratropium bromide in acute asthma. Br Med J. 1981; 1: 598–600.
- Gross NJ, Skorodin MS. Role of the parasympathetic system in airway obstruction due to emphysema. New Engl J Med. 1984; 311: 421–5.
- Pierce RS, Payne CR, Williams SJ, Denison D, Clark TJH. Comparison of intravenous and inhaled terbulatine in the treatment of asthma. Chest. 1981; 79: 506–11.
- Tattersfield AE. Autonomic bronchodilators. In: TJH Clark, Godfrey S. Asthma. Chapman and Hall Medical, London 1983: 301–35.
- Newman SP, Pavia D, Clarke SW. How should a pressurized beta-adrenegic bronchodilator be inhaled ? Eur J Resp Dis. 1981; 62: 321.
- Bloomfield P, Crompton GK, Winsey NJP. A tube spacer to improve inhalation of drug from pressurized aerosols. Brit Med J. 1979; 2: 1479.
- Pauwels R, Lamont H, Hidinger K, Van Der Straeten M. Influence of an extension tube on the bronchodilator efficacy of terbulatine delivered from a metereed dose inhaler. Resp. 1984; 45: 61–6.
- Ellis EP. Theophylline toxicity. In: Jonkman JHG, Jenne JW, Simons FER. Sustained release theophylline in the treatment of chronic reversible airways obstruction. Excerpta Medica, Amsterdam 1983: 33–40.
- Koeter GH, Postma DS, Keyser JJ, Meurs H. The effects of oral slow release terbulatine on early morning dyspnoea. Eur J Clin Pharmacol, (in press).
- Pauwels R, Elinck W, Lamont H, Van Der Straeten M, Ljungholm K.-. A comparison of the clinical and bronchodilating effects of plain and slow-release tablets of terbulatine in steady state (submitted).